Press "Enter" to skip to content

Biotech Stock Roundup: Amgen Gets FDA Nod for Kanjinti, Regeneron Presents Data – Yahoo Finance

admin 0

Biotech Stock Roundup: Amgen Gets FDA Nod for Kanjinti, Regeneron Presents Data  Yahoo Finance

It was a busy week for the biotech sector. The FDA approved Amgen’s AMGN biosimilar for a leading breast cancer drug, Herceptin. Meanwhile, Alexion’s ALXN …

“lymphoma cancer” – Google News

(Visited 4 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *